"Third line therapy" trang 1 - tải miễn phí từ tailieunhanh
A real-world analysis of trametinib in combination with hydroxychloroquine or CDK4/6 inhibitor as third- or later-line therapy in metastatic pancreatic adenocarcinoma

A real-world analysis of trametinib in combination with hydroxychloroquine or CDK4/6 inhibitor as third- or later-line therapy in metastatic pancreatic adenocarcinoma
8    6    1
FOLFOX regimen after failure of fluorouracil and leucovorin plus nanoliposomal-irinotecan therapy for advanced pancreatic cancer: A retrospective observational study

FOLFOX regimen after failure of fluorouracil and leucovorin plus nanoliposomal-irinotecan therapy for advanced pancreatic cancer: A retrospective observational study
8    4    1
Sintilimab Plus Apatinib and Chemotherapy as Second-/Third-Line treatment for Advanced Gastric or Gastroesophageal Junction Adenocarcinoma: A prospective, Single-Arm, phase II trial

Sintilimab Plus Apatinib and Chemotherapy as Second-/Third-Line treatment for Advanced Gastric or Gastroesophageal Junction Adenocarcinoma: A prospective, Single-Arm, phase II trial
10    2    1
Real-world effectiveness of third-line cabazitaxel in patients with metastatic castration-resistant prostate cancer: CARD-like analysis of data from a post-marketing surveillance in Japan

Real-world effectiveness of third-line cabazitaxel in patients with metastatic castration-resistant prostate cancer: CARD-like analysis of data from a post-marketing surveillance in Japan
10    7    1
A single-arm phase II study of nabpaclitaxel for patients with chemorefractory non-small cell lung cancer

A single-arm phase II study of nabpaclitaxel for patients with chemorefractory non-small cell lung cancer
6    63    1
A randomized phase II study of paclitaxel alone versus paclitaxel plus sorafenib in second- and third-line treatment of patients with HER2-negative metastatic breast cancer (PASO)

A randomized phase II study of paclitaxel alone versus paclitaxel plus sorafenib in second- and third-line treatment of patients with HER2-negative metastatic breast cancer (PASO)
9    72    1
Disease characteristics and treatment patterns of Chinese patients with metastatic colorectal cancer: A retrospective study using medical records from China

Disease characteristics and treatment patterns of Chinese patients with metastatic colorectal cancer: A retrospective study using medical records from China
10    36    1
Case report: Continued treatment with alectinib is possible for patients with lung adenocarcinoma with drug-induced interstitial lung disease

Case report: Continued treatment with alectinib is possible for patients with lung adenocarcinoma with drug-induced interstitial lung disease
4    34    1